© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Charles F. Shaefer Jr, MD
Articles
Type 2 Diabetes and America’s “Obesogenic” Mess
July 14, 2012
Type 2 diabetes mellitus is affecting teenagers at an alarming rate. Lifestyle changes are paramount in an environment of chronic caloric surplus.
ORIGIN and Insulin: Old Fears Put to Rest
June 14, 2012
The Outcomes Reduction with Initial Glargine Intervention trial: No elevated risk of cardiovascular disease, cancer when insulin is used early to treat T2DM.
The ADA/EASD Position Statement on Management of Type 2 Diabetes: Winners and Losers
May 31, 2012
The 2012 ADA/EASD Position Statement prescribes patient-centered care for type 2 diabetes management using lifestyle change, metformin, DPP-4Is, GLP-1 RAs.
America's "Obesogenic" Mess
May 02, 2012
New research finds that type 2 diabetes mellitus, once considered a disease of “adult onset,” is highly resistant to treatment in overweight American youths-a group succumbing to the disorder at an alarming rate. Here, a comment on the cultural norms that make choosing health a daily battle.
Insulin or Incretin Becomes Insulin and Incretin
March 24, 2012
The ACP and Its Latest Guidelines on Type 2 Diabetes Mellitus: A View From the Trenches
February 18, 2012
The American College of Physicians (ACP) has recently published its updated guidelines for type 2 diabetes mellitus (T2DM) management. While touted as "new," these guidelines offer no real breakthroughs in understanding. Our blogger offers a perspective; we’d like to hear yours.